VCP is a critical component for TDP-43 disaggregase activity in skeletal muscle
Lynch, E. M.; Pittman, S. K.; Daw, J.; Weihl, C. C.
Show abstract
TDP-43 aggregates are a unifying pathological feature between several neurodegenerative diseases and myopathies. Mutations in the AAA ATPase protein VCP have been linked to TDP-43 proteinopathies in both brain and skeletal muscle including frontotemporal dementia (FTD), amyotrophic lateral sclerosis (ALS), and inclusion body myopathy (IBM). In the case of multisystem proteinopathy (MSP), patients with VCP mutations may present with combinations of these phenotypes. Of these MSP phenotypes IBM is the most common, affecting around 90% of patients. However, it is not well understood how mutations in VCP contribute to the accumulation of insoluble TDP-43 aggregates in the context of skeletal muscle. To study this further, we used in vitro and in vivo models of TDP-43 aggregation in skeletal muscle in the presence of VCP mutation or inhibition to study its effects on the ability to clear TDP-43 aggregates. Across multiple model systems we found that VCP disease mutations or inhibition causes a reduced capacity to clear insoluble TDP-43, suggesting a VCP loss of function in patients with VCP-related MSP.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Knockout of Rab27b exacerbates neuropathology in alpha-synuclein mouse models 92%
- White adipose tissue undergoes pathological dysfunction in the TDP-43A315T mouse model of amyotrophic lateral sclerosis (ALS) 91%
- Neuropathology of RAN translation proteins in Fragile X-associated Tremor/Ataxia Syndrome 90%
Similar papers in this journal
- TMEM106B modifies TDP-43 pathology in human ALS brain and cell-based models of TDP-43 proteinopathy 93%
- Nuclear depletion of RNA binding protein ELAVL3 (HuC) in sporadic and familial amyotrophic lateral sclerosis 91%
- Selective Vulnerability of Tripartite Synapses in Amyotrophic Lateral Sclerosis. 91%
Similar papers in this journal
- Glycolysis upregulation is neuroprotective as a compensatory mechanism in ALS 94%
- A Drosophila model of neuronal ceroid lipofuscinosis CLN4 reveals a hypermorphic gain of function mechanism 93%
- Enrichment of SARM1 alleles encoding variants with constitutively hyperactive NADase in patients with ALS and other motor nerve disorders 92%
Similar papers in this journal
- LRRK2 G2019S kinase activity triggers neurotoxic NSF aggregation 91%
- CYP2D6 variants in amyotrophic lateral sclerosis: an association study of risk and survival 90%
- Structural context of homomeric interactions in the Ig domain of the MPZ (P0) myelin adhesion protein and relation to Charcot-Marie-Tooth disease phenotype variants 90%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.